Plasma YKL-40 in Inuit and Danes.
Copenhagen, Denmark. In Alcohol Alcohol, 20 Nov 2014
AIMS: The aim of the present study was to investigate whether there are differences in plasma levels of YKL-40 between Inuit in Greenland and in Denmark and in Danes, as well as to study the relationship between alcohol intake, plasma YKL-40 and other factors in Inuit.
Adult asthma biomarkers.
Suwŏn, South Korea. In Curr Opin Allergy Clin Immunol, Feb 2014
YKL-40 is associated with asthma severity and airway remodeling.
Expression of CHI3L1 and CHIT1 in osteoarthritic rat cartilage model. A morphological study.
Catania, Italy. In Eur J Histochem, Dec 2013
In recent years the biological role of chitinases has been studied in relation to different inflammatory diseases and more in particular the elevated levels of human cartilage glycoprotein 39 (CHI3L1) and chitotriosidase (CHIT1) have been reported in a variety of diseases including chronic inflammation and degenerative disorders.
Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.
Boston, United States. In J Neuroimmune Pharmacol, Dec 2013
As an example for using this analytic pipeline, we present an exploratory study of 22 plasma inflammatory biomarkers (IFN-α 2b and -γ, 16 cytokines/chemokines, sIL-2R, sCD14, HA, and YKL-40) in a cohort of HIV-infected individuals with advanced disease, frequent HCV co-infection, and viral suppression on ART.
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma.
New York City, United States. In Front Oncol, Dec 2013
We review the current concept of developing YKL-40 as one of the most promising serum markers for glioblastoma, the recent advances on understanding the role of YKL-40 in gliomagenesis, and the promising evidence emerging from preclinical models on using this protein as a target for anti-glioma therapy.
Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease.
Kuala Lumpur, Malaysia. In Int J Endocrinol, 2012
This review examines potential biological markers, YKL-40, alpha-hydroxybutyrate, soluble CD36, leptin, resistin, interleukin-18, retinol binding protein-4, and chemerin, as they may play significant roles in insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease.